Lipid metabolism in MASLD and MASH: From mechanism to the clinicKeypoints
Summary: Metabolic dysfunction-associated steatotic liver disease/steatohepatitis (MASLD/MASH) is recognised as a metabolic disease characterised by excess intrahepatic lipid accumulation due to lipid overflow and synthesis, alongside impaired oxidation and/or export of these lipids. But where do th...
Saved in:
| Main Authors: | Fabrizia Carli, Giuseppe Della Pepa, Silvia Sabatini, Antonio Vidal Puig, Amalia Gastaldelli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | JHEP Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555924001897 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A diet high in glucose and deficient in dietary fibre causes fat accumulation in the liver without weight gain
by: Sonoko Karino, et al.
Published: (2024-12-01) -
Liver proteomics identifies a disconnect between proteins associated with de novo lipogenesis and triglyceride storage
by: Lewin Small, et al.
Published: (2024-12-01) -
Zbtb7b defines a compensatory mechanism in MASLD‐related HCC progression by suppressing H19‐mediated hepatic lipid deposition
by: Yinglin Han, et al.
Published: (2024-12-01) -
Complete inhibition of liver acetyl-CoA carboxylase activity is required to exacerbate liver tumorigenesis in mice treated with diethylnitrosamine
by: Riya Shrestha, et al.
Published: (2024-11-01) -
Altered mitochondrial unfolded protein response and FGF21 secretion in MASLD progression and the effect of exercise intervention
by: Xinmeng Yuan, et al.
Published: (2025-01-01)